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Microbial metalloenzymes constitute a large library of biocatalysts, a number of which have already been shown to catalyze the
breakdown of toxic chemicals or industrially relevant chemical transformations. However, while there is considerable interest in
harnessing these catalysts for biotechnology, for many of the enzymes, their large-scale production in active, soluble form in
recombinant systems is a significant barrier to their use. In this work, we demonstrate that as few as three mutations can result
in a 300-fold increase in the expression of soluble TrzN, an enzyme from Arthrobacter aurescenswith environmental applica-
tions that catalyzes the hydrolysis of triazine herbicides, in Escherichia coli. Using a combination of X-ray crystallography, ki-
netic analysis, and computational simulation, we show that the majority of the improvement in expression is due to stabilization
of the apoenzyme rather than the metal ion-bound holoenzyme. This provides a structural andmechanistic explanation for the
observation that many compensatory mutations can increase levels of soluble-protein production without increasing the stabil-
ity of the final, active form of the enzyme. This study provides a molecular understanding of the importance of the stability of
metal ion free states to the accumulation of soluble protein and shows that differences between apoenzyme and holoenzyme
structures can result in mutations affecting the stability of either state differently.
Approximately half of all known proteins contain a metal ioncofactor in their mature form (1). These metal ions can play
structural or catalytic roles, and their incorporation into apoen-
zyme folding intermediates is an important step in the overall
folding pathway (2). One of the most diverse superfamilies of
enzymes, which includes a large number of microbial enzymes
that are capable of catalyzing the hydrolysis of toxic synthetic
compounds (3–5), is the metal ion-dependent amidohydrolase
superfamily (6, 7). Unfortunately, many of these proteins form
insoluble aggregates or are produced only at very low levels when
overexpressed in recombinant systems.
There is a need to improve heterologous protein expression in
order to enable us to characterize proteins in the laboratory or to
produce proteins on a large scale for industrial or medical pur-
poses. Heterologous overexpression of proteins is often less than
ideal because of protein aggregation or degradation (8). This can
arise due to differences between the native folding situation and
that which occurs when expression levels are much higher and in
a different host, such as a lack of suitable folding chaperones,
different pH, high local concentration of the protein, or the ab-
sence of a cofactor, which is particularly important for metallo-
proteins. The technique of laboratory evolution has great poten-
tial for improving soluble-protein production and involves
subjecting the protein to random mutagenesis and recombina-
tion, followed by screening of the many variants that are produced
for enhanced expression (9, 10). Although there have been a few
successful examples of rationally engineering proteins to enhance
expression of the soluble form (11), our limited understanding of
protein folding and stability currently imposes a limit on this ap-
proach. Thus, a simple means by which mutations that increase
expression can be identified would be very useful.
Stabilizing mutations are also of interest in the context of mo-
lecular evolution and protein engineering; the “trade-off” be-
tween protein stability and function as a result of the accumula-
tion of mutations during evolution is relatively well understood at
a conceptual level. Because most mutations that change protein
function are destabilizing, each step toward a new function in-
creases the probability that the protein will become less stable
(12–14). To overcome this, proteins must rely on the actions of
molecular chaperones to sustain them in their unstable states or
accumulate compensatory, stabilizing mutations (15, 16). Indeed,
there is a clear association between the operational stability of a
protein (the point at which it irreversibly unfolds) and its toler-
ance for amino acid substitutions, or evolvability (17–19). How-
ever, recent work has shown that some compensatory mutations
that increase or maintain protein solubility do not affect the sta-
bility of the functional protein (20), leading to the suggestion that
they might instead specifically stabilize folding intermediates
along the pathway to the mature protein. Although this is well
characterized at the phenotypic level, our structural understand-
ing of the phenomenon is lagging, and it is unclear how these
compensatory mutations can improve or rescue poorly expressed
proteins.
The triazine hydrolase (TrzN) from Arthrobacter aurescens
TC1 (21, 22) is one example of a potentially useful enzyme for
which low levels of soluble-protein production in recombinant
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systems is a problem. This Zn2-dependent metalloenzyme has
evolved since the introduction of the s-triazine herbicides atrazine
and ametryn (23) to efficiently hydrolyze and detoxify these com-
pounds (21, 24). TrzN is potentially of great environmental value;
atrazine and ametryn are widely used (25) and environmentally
persistent (26), which has resulted in toxicologically relevant con-
centrations of atrazine being detected in both surface and ground
water in several countries (27–29). Although not acutely toxic to
vertebrates (23), both short- and long-term exposure to atrazine
concentrations above the maximum contaminant level in drink-
ing water can potentially cause a number of chronic health prob-
lems (30), while off-target effects on aquatic organisms and vege-
tation present further environmental concerns (31, 32). The
breakdown of triazine herbicides by TrzN provides a possible so-
lution to the environmental and public health problems associ-
ated with their use without sacrificing the significant economic
benefits they provide in crop production (33). Indeed, the addi-
tion of a free-enzyme formulation of TrzN to contaminated wa-
terways has been shown to significantly reduce atrazine concen-
trations (34). However, native TrzN cannot be produced at even
moderate yields in Esherichia coli, thereby limiting its usefulness.
In this work, we subjected TrzN to a directed-evolution exper-
iment in order to increase its soluble-protein production. Variants
that were produced at significantly higher levels than the native
protein were then analyzed structurally and kinetically to deter-
mine the molecular basis of these improvements.
MATERIALS AND METHODS
Mutagenesis and library screening. Codon-optimized trzN was kindly
provided by S. Kotsonis (Orica Australia, Ltd., Australia) and was used as
the template in all subsequent work. Random mutagenesis was performed
using GeneMorph II (Stratagene, USA) and the primers TrzNF and
TrzNR (see Table S2 in the supplemental material), with a mutagenesis
rate of 1 to 2 per kbp. The amplicons produced by random mutagenesis
were cloned into pET14b (Novagen) via the NdeI and BamHI restriction
sites (Fermentas). Site-directed mutagenesis of trzN and variants was per-
formed by the overlapping-PCR method using the primers TrzNF and
TrzNR and appropriate mutagenic primers (see Table S2 in the supple-
mental material). The amplicons produced by site-directed mutagenesis
were cloned into pET14b via the NdeI and BamHI restriction sites.
Libraries of TrzN variants were screened by plate-clearing assay. LB
agar was supplemented with 1 g liter1 Gesaprim 900 WG (90% [wt/wt]
atrazine; Syngenta), producing a homogeneous suspension of atrazine. E.
coli BL21 DE3 (Novagen) cells were transformed with libraries of ran-
dom trzNmutants, plated to a density of approximately 500 CFU per petri
dish (9-cm diameter), and grown at 37°C for up to 2 weeks. At least 40,000
colonies were screened in each round of mutagenesis. Colonies that de-
veloped clearing zones more rapidly than colonies containing the mu-
tagenesis template were picked, their plasmids were isolated (Nucleospin;
Macherey-Nagel), and their trzN genes were sequenced (Micromon; Mo-
nash University, Melbourne, Australia).
Protein expression, purification, and quantification. Derivatives of
pET14b containing trzN and its variants were used to transform BL21
DE3 cells. Protein expression was induced by incubation at 37°C for 48 h
in LB medium containing 1 M isopropyl--D-1-thiogalactopyranoside
(IPTG) (Sigma). The expression cultures were harvested by centrifuga-
tion (5,800 g), resuspended in binding buffer (50 mM HEPES [Sigma],
50 mM NaCl [Ajax Finechem], pH 7.5), and then lysed using either Bug-
buster (Novagen) or a French pressure cell. The cell lysates were clarified
by centrifugation (20,000 g), and soluble TrzN and variants were puri-
fied from the clarified cell extracts by immobilized metal affinity chroma-
tography (Talon Co2 resin; Clontech) and size exclusion chromatogra-
phy (Superdex 200; GE Healthcare Life Sciences) on an AKTA fast protein
liquid chromatography (FPLC) system (Amersham Biosciences). Frac-
tions (0.5 ml) were collected at a flow rate of 0.1 ml/min, and absorbance
was measured at 280 nm. Protein purity was monitored using precast
reducing 4 to 20% SDS-PAGE gels (NuSep) stained with Coomassie bril-
liant blue (Sigma). The protein was stored in 50 mM HEPES, pH 7.5, 100
mM NaCl. The enzyme concentration was determined by measuring ab-
sorbance at 280 nm in 6 M urea, using the extinction coefficient 61,670
M1 cm1 for a monomer. The level of expression of variants, relative to
the total soluble protein was estimated using the public domain software
Image J (35), which can calculate area and pixel value statistics of user-
defined selections. Briefly, scanned SDS-PAGE images were converted to
8-bit grayscale JPEG files, two-dimensional (2D) plots of gel lanes were
produced, and the area of the peak corresponding to TrzN was calculated
and compared to the area corresponding to the total soluble protein.
Proteins were coexpressed with a variety of chaperone systems to test
whether expression could be enhanced. The chaperone coexpression sys-
tems (TaKaRa, Japan) were (i) the GroES/GroEL complex (pGro7) and
(ii) GroES/GroEL in combination with DnaK, DnaJ, and GrpE (pG-KJE8)
(36). Cultures containing these plasmids were grown in the presence of
the antibiotic markers ampicillin (50 g/ml) and chloramphenicol (20
g/ml). Coexpression of the chaperones was carried out using the induc-
ing agent arabinose at a concentration of 0.15 mg/liter, consistent with
previous work (37). Coexpression of chaperones was confirmed using
SDS-PAGE.
Enzyme assays. Hydrolysis of atrazine was quantified spectrophoto-
metrically (SpectraMax 190) by the decrease in absorbance at 264 nm that
accompanies atrazine dechlorination, as described previously (38). Assays
and standard curves used an analytical standard of99.5% pure atrazine
(Sigma), and all measurements were made in triplicate. The values for
Vmax and Km were determined from a fit of the data to the following
equation (equation 1):
v Vmax A ⁄ Km A (1)
where 	 is the initial velocity, Vmax is the maximum velocity, Km is the
Michaelis constant, and A is the substrate concentration. The kcat was
calculated by dividing Vmax by the concentration of enzyme used in the
reaction (Vmax 
 kcat[E]).
To measure the metal ion binding affinity, apo-TrzN was incubated
with increasing concentrations of Zn2 for 30 min before measurement of
the rate of atrazine dechlorination (Vmax). The data were fitted to the
following equation (equation 2):
Kd apoTrzNZn2 ⁄ holoTrzN (2)
where Kd is the metal ion concentration at which 50% maximum activity
is regained, assuming one metal ion per subunit.
Protein stability measurements. Enzyme stability was measured by
incubating the enzymes at six temperatures between 40 and 60°C for 15
min prior to kinetic analysis at 25°C. The residual activity (Vmax) was then
plotted as a function of the incubation temperature; this generated a sig-
moidal curve in which the inflection point, or Tm
50(app) (melting point),
of the transition between folded and unfolded protein is calculated using
a Boltzmann function (equation 3):
y ymin
ymax ymin
1 e
T Tm

(3)
where ymin and ymax are the values of the minimum and maximum activ-
ities, T is the temperature of preincubation, Tm [Tm
50(app) for residual-
activity measurements] is the melting temperature, and  denotes the
slope of the curve within Tm.
For the measurement of apoenzyme stability and comparison to the
holoenzyme, thermal unfolding of the proteins was studied by measuring
the molar ellipticity of protein samples using a Chirascan circular-dichr-
oism (CD) spectropolarimeter (Applied Photophysics) with a quartz cell
at 220 nm. A linear ramp of temperature was performed from 20°C to
80°C, with a band width of 1 nm and a ramping rate of 1°C/minute. The
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signal from a buffer sample was subtracted from each run. The transition
between folded and unfolded protein was calculated using equation 3.
Crystallization, data collection, and structure determination. Both
proteins were concentrated to 20 mg/ml in crystallization buffer (50 mM
HEPES, pH 7.5, 100 mM NaCl). The crystallization used a protocol
slightly modified from that previously used to obtain crystals of native
TrzN (38). For holo-TrzN-G3, the crystallization buffer also included 100
M ZnCl2. Crystals grew several days after mixing the protein solution
with precipitant solution (100 mM Bis-Tris [2,2-bis(hydroxymethyl)-
2,2=,2-nitrilotriethanol], pH 5.5, 200 mM NH4SO4, 30% [wt/vol] poly-
ethylene glycol [PEG] 3350) in the hanging droplets (2 l reservoir:1 l
protein) over a reservoir consisting of the precipitant solution. The con-
centration of PEG 3350 was increased to 35% for use as a cryoprotectant
during flash cooling of the crystals to 100 K under a stream of nitrogen gas.
Diffraction data for apo-TrzN-G3 were collected at the MX2 beamline of
the Australian Synchrotron at a wavelength of 1.2398 Å. Diffraction data
for holo-TrzN-G3 were collected at ID23-2 of the European Synchrotron
Radiation Facility at a wavelength of 0.8726 Å. The diffraction data were
indexed and integrated with the XDS package (39) and scaled using AIM-
LESS (40). Molecular replacement solutions were found using MOLREP
(41), and the structure was refined with REFMAC (42) and phenix.refine
(43). Iterative model building was performed using COOT (44). Anom-
alous difference density maps were produced for the apo-TrzN-G3 struc-
ture as described previously (45). All protein structure diagrams were
produced using PyMol (46).
Computational simulations. Starting structures for apo-TrzN-G3
were generated from the 1.8-Å-resolution crystal structure (see Table 2).
The positions of residues in the native TrzN structure were taken from
native holo-TrzN (Protein Data Bank [PDB] accession no. 3LS9) (38).
Hydrogens were constructed with ideal stereochemistry. Protonation
states of histidines were assigned by calculating pKa values with the
PROPKA program (47). The orientations of His, Asn, and Gln side chains
in the active site were taken from the crystal structure and verified by
visual inspection. We employed a strategy that has been calibrated and
shown to give reliable results when calculating free energies for other
protein systems. Specifically, we deleted residues that did not have at least
one nonhydrogen atom within a sphere with a radius of 24 Å centered on
the active site. This gave a protein system50 Å in size that contained all
the important catalytic residues. The resulting system was then solvated in
a cubic 70-Å box of water that was replicated periodically in all directions
to allow infinite bulk simulations and an accurate calculation of the long-
range electrostatic interactions. Significant distortions of the protein were
prevented by harmonically restraining all protein atoms between 20 and
24 Å from the sphere’s center to their experimentally determined posi-
tions. All long-range electrostatic interactions were computed with the
particle mesh Ewald (PME) method. Fourteen potassium counterions
were included in the complex to render the simulation systems neutral.
Simulations were performed at constant temperature and pressure with
Berendsen’s algorithm. The complexes were simulated for 5 ns each fol-
lowing 200 ps of thermalization. The CHARMM27 force field (48) was
used for the protein and a slightly modified TIP3P model for the water, in
which the difference is in the Lennard-Jones parameters, as in the
CHARMM version of the model the hydrogens, as well as the oxygen, have
Lennard-Jones interactions (49). We used the NAMD program (50), ver-
sion 2.7, for all molecular dynamics (MD) simulations.
To compare the stabilities of variant and native TrzN, we employed a
standard thermodynamic cycle (51, 52). The molecular dynamics free
energy (MDFE) method reversibly transforms alanine into valine during a
series of MD simulations. For the folded state, we simulated a portion of
the TrzN complex in the center of a 70-Å water box, as explained above.
For the unfolded state, we simulated a tripeptide consisting of a central
alanine or valine with flanking alanines solvated by the same 70-Å water
box. Previous work had shown that this model of the unfolded state gives
good agreement between experimental and computed stability free ener-
gies for other protein systems (53). In the simulations, we gradually
changed alanine into valine by increasing the coupling parameter, , from
zero to one with the values 0.001, 0.01, 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 0.9, 0.95,
0.99, and 0.999 (54). The free-energy derivatives were computed at each 
value from a 100-ps MD simulation, or window. The last 80 ps of each
window were used for averaging. A complete mutation run consisted of 12
windows and 1.2 ns of simulation. Ten runs were performed in each
direction, starting from equilibrated structures separated by 0.2 ns of dy-
namics. This gave 24 ns of simulation time per protein, or 72 ns of simu-
lation in total. Stability free-energy differences were calculated as the dif-
ferences in the computed free energies of the unfolded, reference, and
folded protein simulations. To estimate the uncertainty in the MDFE
simulation results, we performed forward-backward pairs of runs, one in
each direction, and took the uncertainty to be the corresponding standard
deviation.
To test whether we could computationally predict the thermodynamic
stability changes of mutations in a high-throughput manner, we used the
protein design tool FoldX (version 2.52), following a four-step procedure
that has previously been described in detail (14, 55, 56). The structure of
apophosphotriesterase (apo-PTE) (PDB accession no. 1PTA) was ob-
tained from the PDB and optimized using the repair function of FoldX
before structures of the A80V variant generated in holo-PTE and apo-PTE
were constructed using the buildmodel command, as well as self-muta-
tions (e.g., A80A). The energy calculation function of FoldX was used to
calculate the energies of the variants, which were compared with the en-
ergies of the native structures to obtain G values. These were then
normalized based on prior work (GEXP 
 [GFOLDX  0.78]/1.14)
(56).
Protein structure accession numbers. The coordinates of holo-
TrzN-G3 and apo-TrzN-G3 have been deposited in the PDB under acces-
sion numbers 4LH8 and 4L9X, respectively.
RESULTS AND DISCUSSION
Laboratory evolution to increase whole-cell dechlorinase activ-
ity. When heterologously produced in E. coli, only very small
amounts (0.2 mg protein per liter Terrific Broth [TB] medium)
of correctly folded, active native TrzN (TrzN-N) were produced
(Fig. 1), consistent with previous work (37). To improve the yield
of its soluble form, we performed laboratory evolution, using a
method that we have previously used with related metallohydro-
lases from Pseudomonas sp. strain ADP (AtzA [atrazine chlorohy-
drolase]) and Agrobacterium radiobacter (phosphotriesterase) (5,
57). This involved screening libraries of random variants using an
agar plate-based activity screen in which substrates were included
in the agar gel at concentrations in excess of the solubility limit,
resulting in opaque plates. Because of the greater solubility of the
breakdown products, enzyme-catalyzed substrate hydrolysis con-
ferred a “clearing” phenotype, in which an area of translucent agar
is visible around colonies expressing active enzyme.
Three rounds of random mutagenesis with recombination
FIG 1 SDS-PAGE showing the increase in expression of soluble TrzN by
laboratory evolution. The molecular mass marker is shown in lane M. Lanes 1
to 4 show the increasing cellular concentrations of expression of soluble TrzN
in rounds 1 (lane 2; A159V), 2 (lane 3; A159V/L131P), and 3 (lane 4; A159V/
L131P/D38N) compared with the native TrzN (lane 1).
300-Fold-Increased Production of TrzN
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were performed, screening mutant libraries of 50,000 colonies
per round. As expected from the very low levels of soluble expres-
sion, colonies producing TrzN-N took approximately 350 h of
incubation at room temperature before exhibiting a “clearing”
phenotype (see Fig. S1 in the supplemental material). However,
after three generations of random mutagenesis and recombi-
nation, the whole-cell activity of the most active variant (TrzN-
G3; D38N/L131P/A159V) had increased so that clearing oc-
curred in less than 12 h. SDS-PAGE and kinetic analysis
indicated that the vast majority of this improvement in whole-
cell activity was a result of at least 336-fold-increased expres-
sion (0.2 mg/liter versus 67.2 mg/liter), with the kinetic pa-
rameters changing little from previously published values (Fig.
1 and Table 1) (37). Similar results were obtained from gel
densitometry, where the percentage of total protein increased
from less than 0.1% to approximately 7%.
A combinatorial library of the three mutations from the high-
est-expressing variant was created to analyze their effects on the
expression and stability of the enzyme. The effects of the A159V
and L131P mutations in the wild-type background on soluble-
protein yield appear to be additive: the A159V mutation has the
largest effect in isolation (42-fold), followed by L131P (3-fold). At
the double-mutant stage, addition of the L131P mutation to the
A159V background again led to a 3-fold improvement in soluble-
protein production. In contrast, the D38N mutation had no mea-
surable effect in the wild-type background but resulted in2-fold
improvement in soluble-protein production once combined with
the A159V mutation in rounds 2 and 3.
We observed that the majority of protein production for
TrzN-N was in the insoluble fraction and that the amino acid
substitutions did not significantly affect the ratio of soluble to
insoluble protein, i.e., TrzN-G3 exhibited an increase in both sol-
uble- and insoluble-protein production (see Fig. S2 in the supple-
mental material). Additionally, soluble-TrzN-N production de-
creased over time, from a maximum of 0.4% total protein between
2 and 5 h to 0.2% protein from 6 to 20 h, as measured by gel
densitometry, unlike TrzN-G3 (see Fig. S3 in the supplemental
material), which comprised approximately 2% of the total soluble
protein throughout the 20-hour induction period. This suggests
that TrzN-N is significantly less stable and that a significant pro-
portion of the protein that successfully folds to a soluble state
eventually unfolds, leading to degradation/proteolysis. The large
amount of insoluble protein indicates that protein aggregation is a
more common fate than proteolysis/degradation. It is unlikely
that the improved levels of soluble-protein production are a result
of improved protein translation, since the native protein is ex-
pressed at high levels but in an insoluble form. Additionally, the
mRNA transcripts from these variants differ by only 1 bp out of
1,359.
There are three points at which synthesized metalloprotein can
be degraded or aggregate, leading to a reduction in soluble-pro-
tein accumulation: (i) folding of the nascent polypeptide, (ii) un-
folding/aggregation of the apoenzyme, or (iii) unfolding/aggrega-
tion of the holoenzyme. To understand how these mutations have
resulted in such a large increase in soluble-TrzN-G3 accumula-
tion, we investigated all three possibilities.
Folding chaperones donot significantly improve production
of soluble TrzN. Previous work has shown that overexpression of
native folding chaperones does not significantly improve the ex-
pression and stability of TrzN-N (37). To confirm this and to
investigate in more detail, we coexpressed TrzN-N with two sets of
chaperonins/chaperones known to aid the folding of nascent
polypeptides at different stages: (i) the GroES/GroEL complex,
which binds to polypeptides and encapsulates them in an environ-
ment that strongly favors compact protein folding and (ii) GroES/
GroEL in combination with DnaK, DnaJ, and GrpE, which pre-
vent aggregation/degradation of nascent polypeptides via binding
to hydrophobic patches as they are released from the ribosome
(36).
The use of folding chaperones/chaperonins did not signifi-
cantly improve the yield of soluble protein (see Fig. S4 in the
supplemental material). Although this is not uncommon for re-
combinant proteins, it does suggest that the initial folding steps of
TrzN-N are less likely to be the bottleneck to its soluble expression
than instability of one of the folded states, either with or without
bound metal ions.
Holoenzyme stabilization has minimal effect on the level of
soluble-protein accumulation.To test the effects of the three mu-
tations on the stability of the fully folded, active, Zn2-bound
holoenzyme (holo-TrzN-N), we measured residual activity after
heating at a range of temperatures (Table 1). Of the three substi-
tutions, the only one that appeared to have a stabilizing effect on
holo-TrzN-N is D38N: in the L131P background it resulted in a
1°C increase in Tm
50(app), in the A159V background a 2.6°C in-
crease, and in the L131P/A159V background a 2.6°C increase. In
contrast, the A159V mutation had virtually no effect on holoen-
zyme stability, and the L131P mutation was marginally destabiliz-
ing in most combinations. Given the large change in soluble ex-
pression, it is notable that the Tm
50(app) of the final 3rd-round
variant holo-TrzN-G3 (D38N/L131P/A159V) is only 1.5°C higher
than that of holo-TrzN-N.
To investigate the effects of these mutations on the metal-
bound form of the enzyme in more detail, we solved the crystal
structure of holo-TrzN-G3 by molecular replacement, using the
published native holo-TrzN coordinates (Table 2) (38). N38 is
located in a solvent-exposed loop between strands 12 and 13 in the
peripheral-sandwich domain and extends into the solvent in the
same orientation as D38 in TrzN-N (Fig. 2A). Although there is no
obvious structural explanation for its stabilizing effect, it is possi-
ble that this mutation results in a subtle change to the protein
hydration shell. L131 is located on a loop of the upper face of the
TABLE 1 Effects of mutations in TrzN on protein yield, stability, and
kinetic parametersa
Amino
acidsb
Yield
(mg/liter)
Tm
50(app) (oC)
(holo-TrzN)
kcat
(s1)
Km
(M)
kcat/Km (10
5
M1 s1)
D, L, A 0.2 52.1 2.1 19.7 1.1
N, L, A 0.1 ND 2.6 21.3 1.2
D, P, A 0.6 51.3 3.1 48.6 0.6
D, L, V 8.4 51.8 2.8 18.9 1.5
N, P, A 1.2 52.3 3.2 52.2 0.6
N, L, V 14.4 54.4 2.6 21.7 1.2
D, P, V 28.2 51.0 3.2 54.2 0.6
N, P, V 67.2 53.6 3.7 53.0 0.7
a Yield was measured as purified protein, stability was measured as the temperature at
which 50% activity was lost (68), and kinetic parameters were measured with atrazine
as the substrate using a previously published protocol (38). The Tm
50(app) values could
not be determined for the majority of the apoenzyme samples because the protein
immediately unfolded upon removal of the metal ion.
b Amino acids at positions 38, 131, and 159, respectively.
Jackson et al.
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(/)8 barrel domain between strands 2 and 3 and partly consti-
tutes the substrate-binding pocket (Fig. 2C). The only significant
difference in the kinetic parameters between TrzN-N and the vari-
ants in Table 1 is a slight increase in the kcat and Km in variants
containing L131P. This is consistent with a minor increase in the
volume of the active site as a result of the L131P mutation. Finally,
A159 is located on strand 3 of the (/)8 barrel domain, beneath
the metal ion binding site, and fills a small hydrophobic cavity
(Fig. 2E). The A159V mutation does not significantly change the
structure in this region. Thus, apart from a slight increase in the
size of the active-site binding pocket, the tertiary structures of
TrzN-G3 and TrzN-N are almost identical.
The insignificant structural changes shown here are consistent
with the insignificant changes to the stability of the holoenzyme.
To test the possibility that the mutations affected another state of
the protein, we turned our attention to the metal-ion-free apoen-
zyme, apo-TrzN.
Apo-TrzN is less stable than holo-TrzN. The publication of
the structure of native TrzN confirmed that it is a Zn2-dependent
metalloenzyme (38). Closer inspection of the active site reveals a
unique metal ion coordination sphere in the amidohydrolase su-
perfamily, in which a conserved aspartic acid ligand has been lost.
Eight subtypes of metal ion coordination sites have been reported
previously in the amidohydrolase family (4, 7), making TrzN the
first characterized member of the 9th subtype. It is known that the
loss of an aspartic acid metal ion ligand can lower the metal ion
binding affinity of enzymes (58). Indeed, the metal ion affinity of
TrzN-G3 is low (49M) (see Fig. S5 in the supplemental material)
in comparison to intracellular levels of free Zn2 in E. coli (fem-
tomolar) (59), which is potentially a major problem when metal-
loproteins, such as TrzN, are overexpressed recombinantly from
strong promoters at levels several orders of magnitude higher than
in their native host. Indeed, prior work has shown that even when
excess Zn2 is added to the expression medium, overexpressed
metalloenzymes often accumulate primarily as the apoenzyme
and form the holoenzyme only once they bind metal ions postlysis
(60). By knocking out the genes involved in Zn2 homeostasis in
E. coli, it was established that tight control of the free Zn2 con-
centration is essential to prevent Zn2-induced cell toxicity (61).
Thus, although excess Zn2 was provided during cell growth, the
ability of E. coli to maintain low intracellular free-Zn2 concen-
trations means that, when overproduced, TrzN is likely to spend a
significant amount of time as an apoenzyme, making the stability
of this state crucial to the accumulation of the protein.
It was impossible to analyze the stability of apo-TrzN-N quan-
titatively because the purified protein immediately denatured
upon chelation/extraction of the metal ion. Although full quanti-
fication of its stability was not possible, the half-life of apo-
TrzN-N at 4°C is less than 1 h, unlike holo-TrzN-N, which was
stable at this temperature for several weeks. Therefore, it can be
concluded that apo-TrzN-N is significantly less stable than holo-
TrzN-N. In contrast, apo-TrzN-G3 was substantially more stable,
so much so that when purified without excess metal ions in the
lysis or purification buffers, the apoenzyme form was the domi-
nant species isolated from E. coli cells and was stable in purified
form for several weeks. We were thus able to measure its unfolding
using circular-dichroism spectroscopy, determining that it is
3.5°C less stable than the holo-TrzN-G3 (see Fig. S6 in the supple-
mental material).
Stabilizing apo-TrzN results in increased soluble-protein ac-
cumulation. Having established that the apoenzyme forms of
FIG 2 Effects of the mutations in holo-TrzN-G3 (green) (A, B, and C) and
apo-TrzN-G3 (cyan) (D, E, and F). (A and D) The structure of native holo-
TrzN is shown in gray for comparison. The D38N mutation results in little
conformational change in the holo-TrzN-G3 structure, while an alternative
rotamer is adopted in apo-TrzN-G3. (B and E) The L131P mutation results in
an increase in the volume of the active-site binding pocket but no other back-
bone changes in holo-TrzN-G3, whereas in apo-TrzN-G3, the proline residue
stabilizes a tight turn in the alternative backbone conformation. (C and F) The
A159V mutation results in a slight increase in an already very small cavity in
native holo-TrzN, whereas in the rearranged structure of apo-TrzN-G3, a
much larger cavity is formed, which is filled by the A159V mutation.
TABLE 2 Data collection and refinement statistics for structures
reported in this work
Statistic
Valuea
Holo-TrzN-G3 Apo-TrzN-G3
Space group P1 21 1 P1 21 1
Unit cell parameters
a (Å) 57.09 56.11
b (Å) 101.80 101.27
c (Å) 79.89 77.23
 (°) 103.2 100.98
Data collection
Wavelength (Å) 0.87260 1.2398
Resolution range (Å) 48.78–1.80 (1.90–1.80) 48.34–1.85 (1.95–1.85)
No. of unique reflections 82,249 72,046
Redundancy 3.9 (3.8) 3.7 (3.7)
Completeness (%) 100 (100) 100 (100)
Rmerge(I)
b 0.071 (0.610) 0.025 (0.521)
Mean I/(I) 11.0 (2.1) 14.6 (2.4)
Refinement
No. of reflections (total) 82,036 68,057
Resolution range 48.8–1.8 (1.82–1.80) 19.8–1.85 (1.90–1.85)
Rwork/Rfree
c 0.1767/0.2181 (0.2804/0.3067) 0.1884/0.1914 (0.292/0.289)
RMSd deviations
Bond lengths (Å) 0.006 0.008
Bond angles (°) 0.966 1.108
PDB ID 4LH8 4L9X
a Values in parentheses are for the highest-resolution shell.
b Rmerge(I) 
 (hkl j |Ihkl,j Ihkl|)/(hkl j Ihkl,j), where Ihkl is the average intensity
of j symmetry-related observations of reflections with Miller indices hkl.
c Rwork 
 hkl|F(obs)  F(calc)|/hkl|F(obs)|; 5% of the data that were excluded from the
refinement were used to calculate Rfree.
d RMS, root mean square.
300-Fold-Increased Production of TrzN
July 2014 Volume 80 Number 13 aem.asm.org 4007
 o
n
 July 31, 2018 by G
lasgow University Library
http://aem
.asm
.org/
D
ow
nloaded from
 
both TrzN-N and TrzN-G3 are less stable than the holoenzyme
forms and that the stability of apo-TrzN-G3 is significantly in-
creased through incorporation of the mutations, we investigated
the effects of the three mutations on the apoenzyme in detail by
solving the crystal structure of apo-TrzN-G3 (Table 2). To con-
firm that no metal ions were present in the crystal, we used anom-
alous X-ray scattering by collecting diffraction data slightly above
the Zn-K absorption edge using tuneable synchrotron radiation
(45). Neither subunit within the asymmetric unit was found to
contain significant levels of Zn (see Fig. S7 in the supplemental
material).
The structure of apo-TrzN-G3 is significantly different from
that of holo-TrzN-G3 in two regions, with the C- main chain
adopting a different position in the adjacent loops 2 (residues 131
to 139) and 3 (residues 161 to 179) (Fig. 3a), which constitute part
of the metal ion binding site and substrate binding cavity. In the
absence of the metal ion, loop 2 collapses inward to fill the active-
site cavity, mainly via the side chain of F132. The ability of
TrzN-G3 to fluctuate between these two quite different conforma-
tions in the presence and absence of metal ions is shown in Fig. 3b,
in which the B subunit of the holo-TrzN-G3 crystal is shown. This
subunit has only 50% metal ion occupancy, and the two confor-
mations can clearly be seen simultaneously in the same crystal.
There are also a number of changes in the metal-ligating residues:
in apo-TrzN-G3, H65 and H67 share a hydrogen bond and Q128
shares hydrogen bonds with H238 and H236 (Fig. 2F). Large con-
formational changes to metal ion coordination residues and loops
in the absence of metal ions are not uncommon in metallohydro-
lases of this superfamily (62, 63).
Unlike the holo-TrzN-G3 structure, the stabilizing effects of
the L131P and A159V mutations can be easily rationalized in the
apo-TrzN-G3 structure. The L131P mutation precedes F132 on
loop 2, which is inserted into the active-site cavity. This area of the
loop undergoes a tight bend. The cyclic backbone formed by
proline is known to stabilize tight turns in polypeptide chains
(Fig. 2D). Notably, in the holo-TrzN-N and holo-TrzN-G3 struc-
tures, where L131P is slightly destabilizing, the amino acid does
not exist on a turn. The A159V mutation is the central residue in a
large cavity immediately below the active site, which significantly
increases in volume in the apoenzyme relative to the metal-bound
form (Fig. 2F). The stabilizing effect of this residue, therefore,
relates to its ability to fill and stabilize this cavity. In contrast, in the
holo-TrzN-N and holo-TrzN-G3 structures, the size of the cavity
does not significantly change. The N38D mutation has no clear
effect on the apo-TrzN-G3 structure; it extends into the solvent,
albeit in a slightly different conformation than in the holo-
TrzNG3 or native structure (Fig. 2B). This analysis provides some
explanation for the often-cited view that stability effects are too
subtle to rationalize, i.e., the effects are apparent only when we
investigate the state that they specifically affect.
To better understand the reasons for the stabilizing influence
of the A159V substitution in apo-TrzN-G3, we carried out molec-
ular-dynamics free-energy calculations. In brief, A159 was revers-
ibly transformed to V159 during a series of MD simulations of
both apo- and holo-TrzN, and also of a model of TrzN in an
unfolded state. The stability free energies were then calculated as
the differences between the mutation free energies computed for
the unfolded reference state and those of the folded forms. The
effect on the computed stability free energy of the A159V muta-
tion on apo-TrzN was very large: a G value of 4.29 kcal/mol
compared to a G value of 0.43 kcal/mol for holo-TrzN (see
Table S1 in the supplemental material). Thus, our simulations are
in agreement with the experimental data, which show that the
A159V mutation strongly stabilizes apo-TrzN but that it has es-
sentially no effect on the stability of holo-TrzN.
Compensatory mutations increase expression by increasing
the stability of folding intermediates and can be predicted
through calculation. While most attention is understandably fo-
cused on engineering or manipulating the active metal-ion-bound
form of potentially useful proteins, the work presented here sug-
FIG 3 Comparison between apo-TrzN-G3 and holo-TrzN-G3. (a) Two loops undergo conformational change as a result of metal binding, with loop 2
(H130-Y141) in apo-TrzN-G3 (red) moving out of the active site in holo-TrzN-G3 (green). Loop 3 (S161-P180) undergoes a smaller change from apo-TrzN-G3
(magenta) to holo-TrzN-G3 (blue), which results in opening of the gorge to the active site. (b) Density from a single protein crystal structure in which the Zn2
site is occupied at only 50%. The 2mfo-Dfc, calc map (blue) is contoured at 1, with the holo-TrzN-like chain model colored cyan (50% occupancy); the
mfo-Dfc,calc map (green) is contoured at 2.5, demonstrating that the apo-TrzN-like chain (green; 50% occupancy) is also present in this structure. The second
subunit of the dimer (subunit A) had 100% metal ion occupancy and no detectable density corresponding to apo-TrzN.
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gests that it is the apoenzyme that is sometimes more important in
the context of protein stability, production, and evolvability. In-
terestingly, over 1,000 apoenzyme crystal structures have been
solved and deposited in the PDB, many of which have been unin-
tentionally solved, since the active holoenzyme form is generally
of much more interest. We suggest that structural reassessment of
apoenzyme structures in combination with in silico screening pro-
cedures could be a facile route to rational apoenzyme stabilization
for increased heterologous protein production, as opposed to di-
rected-evolution experiments, for which the screening step can
often be very difficult and/or costly in terms of time and resources.
Because of the high demand for increased protein expression for
laboratory, industrial, and medical applications, these findings
could be used as a simple and effective means to increase the
expression of various metalloproteins for which an apoenzyme
structure is available.
To test whether the insight obtained in this work extends to
other proteins and has applied potential, we tested whether mu-
tations that stabilize apoenzymes could be predicted in a high-
throughput manner using the protein design tool FoldX (64). We
analyzed the structure of a second enzyme; the apoenzyme form of
phosphotriesterase (1PTA), which was first solved in 1994 (65), 1
year before the holoenzyme structure (62). Three directed-evolu-
tion experiments have since been performed on bacterial PTEs to
identify mutations that correlate with increased expression (60,
66, 67). Most recently, Wyganowski et al. and Tokuriki et al. per-
formed an extensive directed-evolution experiment in which the
activity was fully altered from phosphotriesterase to arylesterase.
This required the accumulation of several compensatory muta-
tions that did not affect the operational stability of the functional
protein but did have significant effects on the expression of soluble
PTE (20, 67). Eight mutations have been proposed to increase
production of recombinant PTE: K77E, A80V, R111S, K185R,
A204G, D208G, I274S, and R311S. These mutations were all made
in silico in structures of apo-PTE (1PTA) and holo-PTE (1HZY).
The results were interesting in that two of these mutations (A80V
and R311S) were identified only as stabilizing apo-PTE. Structural
analysis reveals an effect similar to that seen in TrzN (Fig. 4), in
which conformational changes between the apo- and holoen-
zymes result in the mutations affecting each state very differently.
The A80V mutation results in almost no conformational change
in the holo-PTE structure, but in apo-PTE, it results in the adja-
cent L112 adopting a new rotamer in which it fills a hydrophobic
cavity below. Similarly, the R311S mutation in holo-PTE changes
a charged group to a polar group that extends into the solvent
shell, but in apo-PTE, significant structural rearrangement results
in R311 filling a cavity between F306 and M314, with the R311S
mutation allowing F306 and M314 to collapse inward, filling the
cavity and providing a stabilizing effect. This is consistent with the
work of Roodveldt and Tawfik, where they demonstrated that
recombinant PTE mostly exists as the apoenzyme within the cell
(60).
The observation that some other mutations (e.g., R111S,
D204G, and I174S) are not predicted to increase soluble-PTE pro-
duction by increasing apoenzyme stability is not surprising, since
there are other possible mechanisms by which they might increase
expression. Similarly, FoldX will never be completely accurate; for
instance, a crystal structure reveals that the K185R mutation does
stabilize PTE by introducing new salt bridges (68), but it is incor-
rectly modeled by FoldX (see Fig. S8 in the supplemental mate-
rial).
It appears that, in the case of the two proteins examined in this
work (TrzN and PTE), the stabilization of apoenzyme structure
forms of metalloproteins can be an important mechanism by
which evolution can maintain soluble-protein expression. Al-
though only two examples are provided, this analysis suggests that
stabilizing mutations, such as the A80V and R311S mutations in
PTE, which were discovered approximately 10 to 20 years after
publication of the structure of the apoenzyme (65) as a result of
exhaustive directed-evolution experiments (66), might be easily
predicted in other proteins by using computational algorithms
similar to FoldX (64).
This work highlights the sometimes overlooked importance of
apoenzyme and apoprotein stability to microbial physiology and
to the overexpression and potential applications of the many cat-
alytically useful proteins that we can obtain from prokaryotes.
Heterologous expression of proteins effectively places unnatural
and competing demands on cells: on one hand, they must main-
tain intracellular free metal ion concentrations at very low levels to
prevent toxicity, while on the other hand they are forced to trans-
late and fold unnaturally high levels of proteins that often require
exogenous metal ions. Because of the complexity of metal ion
homeostasis and the potential for toxicity, engineering metallo-
proteins to have greater stability in their apoprotein state seems to
be the simplest solution to this problem.
Summary. We used directed laboratory evolution to increase
the levels of soluble, active TrzN heterologously produced by E.
coli over 300-fold. The amino acid substitutions responsible for
this improvement were rationalized at a molecular level, with a
combination of protein crystallography and computational sim-
ulation, demonstrating that apoenzyme stabilization is the key
process involved in the increase in soluble-protein production.
FIG 4 Effects of stabilizing mutations in holo-PTE and apo-PTE. (a) The
A80V mutation (green) results in almost no conformational change in the
holo-PTE structure (gray), only adding two methyl groups at the enzyme
surface. (b) In contrast, in apo-PTE, the A80V mutation (cyan) is predicted to
result in the adjacent leucine (L112) adopting a new rotamer, in which one of
its methyl side chains fills a hydrophobic cavity below, which explains its pre-
dicted stabilizing effect on apo-PTE and increase in expression. (c) The R311S
mutation in holo-PTE (cyan/yellow) results in the loss of a charged group on
the protein surface. (d) In contrast, in apo-PTE, structural rearrangement of
the apoeznyme results in R311 filling a cavity between F306 and M314. The
R311S mutation allows F306 and M314 to collapse inward, filling the cavity
and providing a stabilizing effect.
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This molecular explanation complements recent research that has
established the essential role that compensatory mutations such as
these play in molecular evolution. This work also makes a contri-
bution to the goal of facile rational stabilization of protein struc-
ture for increased protein production, demonstrating that muta-
tions that increase protein production in recombinant hosts can
easily be predicted from existing apoenzyme structures.
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